Submitted on Friday 16th January 2015
Published on Friday 16th January 2015
Current status: Closed
Closed: Monday 30th March 2015
Signatures: 730
Tagged with
Call for reassessment of the Cancer Drugs Fund for blood cancer patients
This is a petition on behalf of blood cancer patients who are concerned about the recent changes made to the Cancer Drugs Fund.
It was announced on Monday, January 12, 2015, that life-extending cancer drugs are to be removed from a list of medicines that are approved for funding via the Cancer Drugs Fund.
This petition calls specifically for a rethink over the de-listing of the following drugs:
Bosutinib and Dasatinib for blast-phase Chronic Myeloid Leukaemia;
The de-listing of Bortezomib for relapsed Myeloma, Mantle-Cell Lymphoma and Waldenstrom Macroglobulinemia;
The de-listing of Bendamustine for non-Hodgkin Lymphoma;
The de-listing of Ofatumumab for relapsed or refractory Chronic Lymphatic Leukaemia;
A re-analysis of the decision to reject Vemurafenib for all Hairy Cell Leukaemia patients and also a re-analysis of the rejection of Idelalisib for Chronic Lymphatic Leukaemia.
You can't sign this petition because it is now closed. But you can still comment on it here at Repetition.me!
18.116.90.141 Sat, 04 May 2024 10:49:11 +0100